New hope for chemo fatigue: drug targets anemia in cancer patients
NCT ID NCT06075030
First seen Mar 03, 2026 · Last updated May 18, 2026 · Updated 6 times
Summary
This study tests a new drug called AND017 for cancer patients who develop anemia (low red blood cells) from chemotherapy. About 36 adults with certain cancers will receive the drug for 6 weeks to see if it safely raises hemoglobin levels and reduces the need for blood transfusions. The goal is to ease the tiredness and weakness caused by chemo-related anemia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY INDUCED ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.